Rofo 2019; 191(07): 643-652
DOI: 10.1055/a-0855-4298
Neuroradiology
© Georg Thieme Verlag KG Stuttgart · New York

Endovascular Treatment of Intracranial Atherosclerotic Stenosis

Artikel in mehreren Sprachen: English | deutsch
Hannes Nordmeyer
1  Department of Interventional Radiology and Neuroradiology, Neurocenter Solingen, radprax St. Lukas Hospital, Solingen, Germany
2  School of Medicine, Department of Health, Witten/Herdecke University, Witten, Germany
,
René Chapot
3  Diagnostic and Interventional Radiology and Neuroradiology, Alfried-Krupp-Hospital, Essen, Germany
,
Patrick Haage
4  Department of diagnostic and interventional Radiology, Helios Universitiy Hospital, Wuppertal, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

11. September 2018

25. Januar 2019

Publikationsdatum:
04. April 2019 (online)

Abstract

Background Intracranial atherosclerotic stenosis (ICAS) causes 5 – 10 % of all ischemic strokes in the European population. Indication for endovascular treatment is a special challenge and the selection of material as well as interventional techniques essentially differs from the treatment of extracranial stenoses. According to recent studies patient selection became evidence based; however the method should not be abandoned. New technical approaches can contribute to avoid complications.

Method We performed a review of the literature with regard to conservative as well as endovascular treatment of ICAS. Different technical approaches are discussed and strategies to avoid complications are stressed. Based on the treatment indication, the positions of the authorities and the professional societies are taken into account.

Results and Conclusion A single self-expanding stent is approved for the treatment of ICAS. Balloon mounted and other self-expanding Stents are available for off-label use. Anatomical conditions and features of the stenosis determine the choice of material. Distal wire perforations causing intracranial bleedings may occur during exchange manoeuvres and constitute one of the technical complications in the treatment of ICAS. In contrast, there is hardly any efficient way to eliminate the risk of ischemia in the territory of perforating arteries arising from the intracranial posterior circulation and the middle cerebral artery. The results of the randomized prospective trials strengthen the conservative treatment of ICAS. Endovascular treatment should not be withheld from patients with either hemodynamic stenosis, recurrent ischemic events under best medical treatment in the territory of the stenosed vessel or acute occlusions of a stenosis.

Key Points:

  • Medical therapy and risk reduction constitute the primary treatment of intracranial stenosis.

  • Recurrence under best medical treatment and acute occlusions of intracranial stenosis are indications for endovascular treatment.

  • Acute occlusions due to intracranial stenosis often are treated by stenting and angioplasty after mechanical thrombectomy.

  • Exchange manoeuvres with distal wire perforation can cause intracranial hemorrhage.

  • Basal ganglia and brain stem ischemia constitute a specific risk in treatment of vessel segments bearing perforators.

Citation Format

  • Nordmeyer H, Chapot R, Haage P. Endovascular Treatment of Intracranial Atherosclerotic Stenosis. Fortschr Röntgenstr 2019; 191: 643 – 652